503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-5.01%
Negative net income growth while ORCL stands at 69.93%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
47.46%
D&A growth well above ORCL's 24.53%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
265.31%
Well above ORCL's 250.00% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-461.50%
Negative yoy SBC while ORCL is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-294.97%
Both reduce yoy usage, with ORCL at -276.84%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-137.86%
AR is negative yoy while ORCL is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-819.94%
Both reduce yoy usage, with ORCL at -276.84%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
8777.78%
Well above ORCL's 147.62%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-28.10%
Negative yoy CFO while ORCL is 51.81%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-146.69%
Negative yoy CapEx while ORCL is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-280.72%
Negative yoy acquisition while ORCL stands at 99.39%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
45.71%
Some yoy expansion while ORCL is negative at -66.30%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-14.74%
Both yoy lines are negative, with ORCL at -68.46%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
33.13%
We have some outflow growth while ORCL is negative at -91.84%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
348.86%
Investing outflow well above ORCL's 80.86%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-531.90%
Negative yoy issuance while ORCL is 239.77%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
14.84%
Buyback growth of 14.84% while ORCL is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.